Bad actors that hinder competition shouldn't be able to delay patient access to generic and biosimilar medicines.
Harley Rouda: “Bad actors that hinder competition shouldn't be able to delay patient access to generic and biosimilar medicines.”
On the recordJanuary 28, 2019
Source
congress.govEditor's note · Context
Rouda criticizes companies that obstruct access to affordable medications.
Share
More from Harley Rouda
Feb 6, 2020
I demand a recorded vote. The Acting CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentleman from California will be postponed. Announcement by the Acting Chair The Acting CHAIR. Pursuant to…
Sep 23, 2020
we all agree that less CO2 emissions is better for our health and the health of our fellow Americans.
Sep 23, 2020
The bottom line is that the industries of the future are not going to be fossil fuel based.
Aug 23, 2020
As you know, there is a bipartisan bill sitting on Mitch McConnell's desk that would eliminate the prefunding mandate and free up tens of billions of dollars for the U.S. Postal Service.





